Dr Livnat Savitzky has experience in the life sciences industry, including drug discovery and development, corporate partnering and capital raising. Dr Livnat Savitzky currently serves as the CEO and a board member of FutuRx Ltd., an Israeli biotechnology accelerator established by OrbiMed Israel Partners. Johnson & Johnson Innovation and Takeda Ventures Inc. (the venture group of Takeda Pharmaceutical Company). Dr Livnat Savitzky also serves on the boards of several biotechnology or healthcare companies. From 2010 to 2016. Dr Livnat Savitzky served as the CEO of NASDAQ-listed BioLineRx Ltd. Prior to being appointed CEO of BioLineRx. she held various research and development management positions at BioLineRx and Compugen. She is also member of Risk Committee of the Company.
Kinneret L Savitzky
Non-Executive Director / Nutritional Growth Solutions